Tech Company Financing Transactions
Marina Biotech Funding Round
Novartis BioVenture Fund invested in a $7.3 million Series D funding round for Marina Biotech. The funding round was announced on 3/23/2009.
Transaction Overview
Company Name
Announced On
3/23/2009
Transaction Type
Venture Equity
Amount
$7,250,000
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
17870 Castleton St. 250
City of Industry, CA 91748
USA
City of Industry, CA 91748
USA
Phone
Website
Email Address
Overview
Marina Biotech (NASDAQ: MRNA), is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Moscato
Chief Financial Officer
Amit Shah
Chief Operating Officer
Erik Emerson
VP - General Counsel
Peter Weinstein
Browse more venture capital transactions:
Prev: 3/23/2009: Ardian venture capital transaction
Next: 3/23/2009: UMDNJ venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs